MMT Funds

Venture Capital Tel Aviv-Yafo, Israel Est. 1998
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Disclosed deployed
—
across known amounts
Stages
—

About

MMT Funds is focused on investing in companies developing advanced materials in the fields of nanotechnology, polymer technologies, biomaterials, energy and environmental technologies, industrial chemistry, and novel crystals, with a special focus on Israeli and Israel-related companies (60-70%). MMT focuses on companies with applications in the life science, microelectronics and semiconductors, and medical device spaces. MMT Fund I, established in 1998, was capitalized at $11 million and is fully invested in nine portfolio companies. MMT Fund II, established in 2000, was capitalized at $40 million and is currently invested in 14 portfolio companies, three of which are follow-on investments to MMT I. In addition to having a material science innovation, the companies MMT invests in have to cater to large, high-growth markets.

Portfolio

No portfolio companies in this dataset yet.

Investor Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is MMT Funds' primary investment focus?
MMT Funds primarily invests in companies developing advanced materials in nanotechnology, polymer technologies, biomaterials, energy and environmental technologies, industrial chemistry, and novel crystals. They focus on applications in life science, microelectronics, semiconductors, and medical devices.
When was MMT Funds established and what was its operational status as of July 2016?
MMT Funds was founded in 1998. As of July 2016, MMT Funds ceased to operate and is listed as inactive.
What was the capitalization and portfolio size of MMT Fund I and MMT Fund II?
MMT Fund I, established in 1998, was capitalized at $11 million and invested in nine portfolio companies. MMT Fund II, established in 2000, was capitalized at $40 million and invested in 14 portfolio companies, including three follow-on investments from MMT I.
What percentage of MMT Funds' investments are focused on Israeli and Israel-related companies?
MMT Funds has a special focus on Israeli and Israel-related companies, accounting for 60-70% of their investments.
Can you name a notable portfolio company and an exit event for MMT Funds?
A notable portfolio company for MMT Funds is Enzymotec. Enzymotec had an exit event via a Public Offering (IPO) on NASDAQ in September 2013.
What is MMT Funds' sector concentration based on its portfolio companies and investment rounds?
According to startupim data, MMT Funds' portfolio companies and investment rounds show a concentration in the Health Tech & Life Sciences sector.
What was the investment range for MMT Funds' individual investments?
MMT Funds' individual investments ranged from $1 million to $2 million.
Who are the key team members at MMT Funds?
The key team members at MMT Funds include Zwi Vromen and Oren Gafri.